Rochester Medical Honored by Premier Healthcare Alliance for Exceeding Performance Ex...(http://www.rocm.com ....),Health
Navigation Links
Rochester Medical Honored by Premier Healthcare Alliance for Exceeding Performance Expectations
Date:6/12/2008
http://www.rocm.com.
'/>"/>
| SOURCE Rochester Medical Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. U.S. Reps. Oberstar and Walz Discuss DM&E Railroad Expansion With Rochester, Minn. Leaders
2. Rochester Medical Reports Record Fourth Quarter Sales and Record Year
3. Rochester Medical Announces First Quarter 2008 Earnings Conference Call February 4, 2008
4. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
5. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
6. Rochester Medical Marketing VP Retires
7. Rochester Coalition and Mayo Clinic Challenge Railroads Contention That Hazmat Rail Shipments Pose no Risk
8. MSU engineering team designs innovative medical device
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
11. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research 2Health News:Seasonal Flu Vaccination Rates Still Too Low 2Health News:Seasonal Flu Vaccination Rates Still Too Low 3Health News:Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award 2Health News:Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 3
[0] Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research[0] Seasonal Flu Vaccination Rates Still Too Low[0] Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award[0] Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010[0] IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care
Other Medicine News:Health News:Surgery safe for babies and toddlers suffering from seizures 2Health News:Inventor of G-Suit Dies 2Health News:Inventor of G-Suit Dies 3Health News:Inventor of G-Suit Dies 4Health News:Boost Your Calcium Consumption - Have a Latte! 2Health News:Boost Your Calcium Consumption - Have a Latte! 3Health News:Learning Empowered by Movement; Brain Gym Exercises Wake Up Brain and Body 2Health News:Stroke survivors improve balance with tai chi 2Health News:Nevada Youth Shares Epilepsy Message On Capitol Hill 2
Surgery safe for babies and toddlers suffering from seizuresInventor of G-Suit DiesBoost Your Calcium Consumption - Have a Latte!Learning Empowered by Movement; Brain Gym Exercises Wake Up Brain and BodyStroke survivors improve balance with tai chiNevada Youth Shares Epilepsy Message On Capitol Hill
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2IPY follow up requires year round research on Arctic and global warming 9894 1Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 1Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 2Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 3Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 4Schofield Media Names Brian Reshefsky Group President 56972 1
Other Medicine Technology:Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 2Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 3Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 4Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 5Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 6Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 7Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 8Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |